Small-bowel tumors represent a rare entity comprising 0.6% of all new cancer cases in the
US, and only 3% of all gastrointestinal neoplasms. They are a heterogenous group of
neoplasms comprising of about forty different histological subtypes with the most common
being adenocarcinoma, neuroendocrine tumors, stromal tumors and lymphomas. Their
incidence has been reportedly increasing over recent years, partly owing to the advances
and developments in the diagnostic modalities. Small-bowel capsule endoscopy, device …